Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 2,980,960 6.600% | 2,980,960 (New Position) | Filing History |
| 2022-02-14 07:17 am Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Euclidean Capital LLC | 2,336,909 5.100% | -118,290 (-4.82%) | Filing History |
| 2022-02-14 06:51 am Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 3,249,544 7.200% | -3,220,367 (-49.77%) | Filing History |
| 2022-02-11 10:06 am Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 1,465,000 3.200% | -885,267 (-37.67%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,647,946 5.840% | 2,647,946 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | BlackRock Inc. BLK | 2,539,824 5.600% | 2,539,824 (New Position) | Filing History |
| 2022-01-26 11:54 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | JPMORGAN CHASE & CO JPM | 3,166,450 6.900% | 3,166,450 (New Position) | Filing History |
| 2022-01-19 3:43 pm Purchase | 2022-01-14 | 13G | PMV Pharmaceuticals, Inc. PMVP | Cowen Financial Products LLC | 2,300,000 5.070% | 2,300,000 (New Position) | Filing History |
| 2021-10-18 3:50 pm Sale | 2021-10-15 | 13G | PMV Pharmaceuticals, Inc. PMVP | Euclidean Capital LLC | 2,455,199 5.400% | -2,218,624 (-47.47%) | Filing History |
| 2021-05-07 5:00 pm Purchase | 2021-04-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | Euclidean Capital LLC | 4,673,823 10.400% | 494,407 (+11.83%) | Filing History |
| 2021-02-16 4:00 pm Purchase | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Nextech V Oncology S.C.S. SICAV-SIF | 2,528,290 5.600% | 2,528,290 (New Position) | Filing History |
| 2021-02-12 7:50 pm Sale | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | VIKING GLOBAL INVESTORS LP | 2,364,062 5.300% | -277,778 (-10.51%) | Filing History |
| 2021-02-12 4:00 pm Purchase | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Euclidean Capital LLC | 4,179,416 9.300% | 4,179,416 (New Position) | Filing History |
| 2021-02-12 08:11 am Purchase | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 2,350,267 5.300% | 2,350,267 (New Position) | Filing History |
| 2021-02-12 06:07 am Purchase | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 6,469,911 14.500% | 6,469,911 (New Position) | Filing History |
| 2020-10-05 5:23 pm Purchase | 2020-09-25 | 13D | PMV Pharmaceuticals, Inc. PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.700% | 6,589,330 (New Position) | Filing History |
| 2020-10-05 5:04 pm Purchase | 2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP | VIKING GLOBAL INVESTORS LP | 2,641,840 6.100% | 2,641,840 (New Position) | Filing History |
| 2020-09-30 4:33 pm Purchase | 2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 2,268,236 5.100% | 2,268,236 (New Position) | Filing History |